# PIoglitazone for PrEvention of Restenosis in Diabetic Patients

> **NCT00376870** · PHASE3 · UNKNOWN · sponsor: **University of Rome Tor Vergata** · enrollment: 160 (estimated)

## Conditions studied

- Coronary Atherosclerosis
- Coronary Restenosis
- Diabetes

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00376870
- **Lead sponsor:** University of Rome Tor Vergata
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2010-12
- **Final completion:** 2011-04
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2008-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376870, "PIoglitazone for PrEvention of Restenosis in Diabetic Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00376870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*